Table 3.
Verification of reference intervals for aspartate amino-transferase for Croatian patients
Analyte | Method | Unit |
Reference interval |
Ref. | Verification (%) | ||
Sex | Age (yr) | Interval | |||||
AST | Photometry UV, IFCC method, 37 °C, TRIS buffer, L-aspartate, α-ketoglutarate, pyridoxal phosphate, NADH, malate dehydrogenase, lactate dehydrogenase, pH 7.65: CCMB recommendation for the Croatian population | U/L | Male, female | 0-2 | 26-75 | [40] | |
Male, female | 3-7 | 24-49 | [40] | ||||
Male, female | 8-12 | 14-39 | [10,15] | ||||
Male | 13-19 | 11-38 | [10,15] | ||||
Female | 13-19 | 14-32 | [10,15] | ||||
Male | ≥ 20 | 11-38 | [14] | ||||
Female | ≥ 20 | 8-30 | [14] | ||||
IFCC reference measurement procedure (IFCC RMS), IFCC IRMM reference material ERM-AD457 (2002): Common multicentric reference intervals for the adult population, 2010 | U/L | Male, female | 18-85 | 11-34 | [41] | 94 | |
Pediatric reference intervals | |||||||
CALIPER, Canada, 2012; IFCC reference measurement procedure, Abbott Architect | Male, female | 1 < 7 | 26-55 | [42] | 100 | ||
Male, female | 7 < 12 | 22-41 | 96 | ||||
Male | 12 < 19 | 18-40 | 96 | ||||
Female | 12 < 19 | 17-33 | 96 | ||||
Denmark (NORIP), 2012; IFCC reference measurement procedure, Roche Modular | Male, female | 5-18 | 17-46 | [43] | |||
Germany (a posteriori, ambulance and hospital populations) 2009; IFCC reference measurement procedure, Roche Modular | Male, female | 0-1 | < 77 | [44] | |||
Male, female | 1-3 | < 71 | |||||
Male, female | 4-6 | < 53 | |||||
Male, female | 7-12 | < 48 | |||||
Male | 13-17 | < 42 | |||||
Female | 13-17 | < 44 |
AST: Aspartate amino-transferase; IFCC: International Federation of Clinical Chemistry and Laboratory Medicine; CCMB: Croatian Chamber of Medical Biochemists; IRMM: Institute for reference materials and measurements; RMS: Reference measurement system; CALIPER: Canadian laboratory initiative on pediatric reference intervals.